The invention relates to a formula of a drug for treating rhinitis. The drug is a tea-bag type composite oral preparation and is utilized for treating acute and chronic rhinitis, nasosinusitis and prosopantritis. The drug for treating rhinitis comprises the following ingredients of angelica sinensis, radix astragali, rhizoma atractylodis macrocephalae, fangshui, keel, oyster, cassia twig, ligusticum wallichii, dahurian angelica root, ligusticum sinense oliver, cimicifuga foetida, flos magnoliae, monkshood, sparganium, curcuma rhizome, catnip, notopterygium root, levisticum, chrysanthemum, radix scrophulariae, radix bupleuri, cape jasmine fruit, the bulb of fritillary, xanthium, white peony root, little lotus, asarum herb, rhizoma anemarrhenae, silver flower, honey-fried licorice root, radix glehniae, poria cocos, tuber of dwarf lilyturf, root of large-flowered skullcap, gentian and mulberry leaf. Through many years of clinical application, the formula based on an ancestral "Bizutang" formula is obtained after modification. Through synergistic effects of the ingredients of the drug for treating rhinitis, the effects of tonifying qi and nourishing yin, promoting and tonifying the lung, activating blood circulation and dissipating blood stasis, clearing heat and draining dampness, reducing swelling and relieving pain, and restoring consciousness and unblocking orifices are obtained. The drug for treating rhinitis has the characteristics of obvious curative effects and convenient drug taking way.